Cyclerion therapeutics, inc. (CYCN)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

0

-

-

-

0

-

-

-

-

Net loss

-

-

-

-

-

-

0

0

0

Adjustments to reconcile net loss to net cash (used in) operating activities:
Depreciation and amortization

2,801

2,700

2,513

2,156

1,697

1,528

0

0

0

Gain on disposal of property and equipment

0

-

-

-

-

-

-

-

-

Gain on lease modification

0

-

-

-

-

-

-

-

-

Share-based compensation expense

19,678

19,631

18,770

17,133

13,914

12,433

0

0

0

Changes in operating assets and liabilities:
Related party accounts receivable

0

-

-

-

-

-

-

-

-

Prepaid expenses

941

1,099

1,464

776

-343

-384

0

0

0

Other current assets

0

-

-

-

-

4

0

0

0

Operating lease assets

0

-

-

-

-

-

-

-

-

Other assets

1,040

515

-36

-49

-43

-55

0

0

0

Accounts payable

-4,247

-331

0

0

0

-

-

-

-

Related party accounts payable

0

-

-

-

-

-

-

-

-

Accounts payable

-

-

-

-

-

-

-

-

0

Accrued research and development costs

-3,562

-3,064

-366

2,493

3,573

356

0

0

0

Operating lease liabilities

0

-

-

-

-

-

-

-

-

Accrued expenses and other current liabilities

-995

-1,556

0

0

0

-

-

-

-

Other liabilities

-

-

-

-

0

-

-

-

-

Accrued expenses and other current liabilities

-

-

-

-

-

-

-

-

0

Net cash (used in) operating activities

-97,124

-102,215

-103,204

-104,696

-105,345

-97,503

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment

6,479

6,888

8,530

9,037

5,090

3,438

0

0

0

Proceeds from sale of property and equipment

0

-

-

-

-

-

-

-

-

Net cash (used in) investing activities

-6,257

-6,715

-8,431

-9,037

-5,090

-3,438

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from exercises of stock options and ESPP

0

-

-

-

-

-

-

-

-

Transfers from Ironwood

-

46,439

71,407

97,871

110,435

100,941

0

0

0

Net cash provided by financing activities

175,487

211,571

236,394

262,493

110,435

100,941

0

0

0

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-18

-20

0

0

0

-

-

-

-

Net decrease in cash, cash equivalents and restricted cash

0

-

-

0

0

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

0

Supplemental cash flow disclosure:
Cash paid for initial direct costs of lease modification

0

-

-

-

-

-

-

-

-

Non-cash investing activities
Fixed asset purchases in accounts payable and accrued expenses

0

-

-

-

0

-

-

-

0